Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1587499

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1587499

Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Orthopedics, Musculoskeletal, & Spine, Urology), By Region And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Tissue Engineering Market Growth & Trends:

The global tissue engineering market size is estimated to reach USD 43.13 billion by 2030, growing at an estimated CAGR of 14.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders, has driven the demand for tissue engineering solutions that can repair or replace damaged tissues. Advances in biomaterials, 3D bioprinting, stem cell research, and gene editing techniques have propelled the field of tissue engineering, enabling the development of complex and functional tissues.

The allogeneic tissue transplant method effectively addresses the challenges and limitations associated with the use and accessibility of autologous transplants. In addition, the advancement of specialized procedures, such as implant fixing and sterilization, aimed at converting allogeneic implants into biostatic implants, is anticipated to boost revenue generation in this market.

Tissue regeneration technology is gaining popularity due to its effective products and low rejection rates, leading to an increase in regeneration treatments. Pre-clinical research is currently focused on the use of tissue-engineered vascular grafts in cardiovascular surgery and treatment. Moreover, tissue-engineered bladders can now be successfully implanted outside of the patient's body. Despite these advancements, the market's growth is hindered by challenges such as the high cost of product development and ethical concerns surrounding stem cell research and tissue-engineered products.

Tissue Engineering Market Report Highlights:

  • The orthopedics, musculoskeletal, & spine segment held the largest revenue of 59.21% market share in 2024, owing to the increasing prevalence of musculoskeletal disorders.
  • North America dominated the market and accounted for the largest revenue share of 51.30% in 2024, owing to rising awareness of stem cell therapy, the growing geriatric population, and the rising incidence of chronic diseases.
  • The market for tissue engineering in Asia Pacific is estimated to witness the fastest CAGR of 19.04% during the forecast period.
Product Code: 978-1-68038-768-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Tissue Engineering Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in stem cell technology & tissue engineering
      • 3.2.1.2. Rise in number of clinical studies for Tissue Engineering and tissue engineering
      • 3.2.1.3. Increasing tissue engineering research funding
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product development
      • 3.2.2.2. Ethical concerns related to stem cell research & tissue engineered product
      • 3.2.2.3. Clinical issues pertaining to development & implementation of stem cell therapies
  • 3.3. Tissue Engineering Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Tissue Engineering Market Application Movement Analysis
  • 4.3. Global Tissue Engineering Market Size & Trend Analysis, by Specimen, 2018 to 2030 (USD Million)
  • 4.4. Cord blood & Cell banking
    • 4.4.1. Cord blood & Cell banking market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Cancer
    • 4.5.1. Cancer market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. GI/Gynecology
    • 4.6.1. GI/Gynecology therapy market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Dental
    • 4.7.1. Dental market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Skin & Integumentary
    • 4.8.1. Skin & Integumentary market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Urology
    • 4.9.1. Urology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Orthopedics, Musculoskeletal, & Spine
    • 4.10.1. Orthopedics, Musculoskeletal, & Spine market estimates and forecast 2018 - 2030 (USD Million)
  • 4.11. Neurology
    • 4.11.1. Neurology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.12. Cardiology & Vascular
    • 4.12.1. Cardiology & Vascular market estimates and forecast 2018 - 2030 (USD Million)
  • 4.13. Others
    • 4.13.1. Others market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Dashboard
  • 5.2. Tissue Engineering Market: Share By Region, 2024 & 2030
  • 5.3. North America
    • 5.3.1. North America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Mexico Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Sweden Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Norway Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Denmark Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. China Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Japan Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Australia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Thailand Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. South Korea Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Brazil Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Argentina Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. South Africa Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Saudi Arabia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. UAE Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Kuwait Tissue Engineering Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Position Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. Zimmer Biomet Holdings, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. AbbVie (Allergan)
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Becton, Dickinson and Company
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. B. Braun
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Integra LifeSciences Corporation
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Organogenesis Holdings Inc.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Medtronic
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. ACell, Inc.
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Athersys, Inc.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Tissue Regenix Group plc
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Stryker Corporation
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. RTI Surgical, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. ReproCell, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Baxter International, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives
Product Code: 978-1-68038-768-1

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global tissue engineering market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 12 Germany tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 14 France tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 17 Sweden tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 18 Norway tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 19 Denmark tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 21 APAC tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 22 China tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 23 Japan tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 24 India tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 25 Thailand tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 30 Argentina tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 31 Middle East and Africa tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East and Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 33 South Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 35 UAE tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 36 Kuwait tissue engineering market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Tissue engineering: market outlook
  • Fig. 9 Tissue engineering competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Tissue engineering market driver impact
  • Fig. 15 Tissue engineering market restraint impact
  • Fig. 16 Tissue engineering market strategic initiatives analysis
  • Fig. 17 Global tissue engineering market: application movement analysis
  • Fig. 18 Global tissue engineering market: application outlook and key takeaways
  • Fig. 19 Global cord blood & Cell Banking market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 20 Global cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global GI, Gynecology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Global dental market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Global skin & Integumentary market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global urology market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 25 Global orthopedics, Musculoskeletal, & Spine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global cardiology & Vascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global tissue engineering market: regional movement analysis
  • Fig. 30 Global tissue engineering market: regional outlook and key takeaways
  • Fig. 31 Global market share and leading players
  • Fig. 32 North America market, SWOT analysis
  • Fig. 33 Europe market, SWOT analysis
  • Fig. 34 Asia Pacific market, SWOT analysis
  • Fig. 35 Latin America market, SWOT analysis
  • Fig. 36 Middle East & Africa market, SWOT analysis
  • Fig. 37 North America
  • Fig. 38 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Participant categorization- Tissue engineering market
  • Fig. 67 Market position of key market players- Tissue engineering market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!